Evaluation of Implementation of ITV-Pal Program
ITV-Pal
Evaluation of Implementation Process of Tech-Volunteer Program in Palliative Care: ITV-Pal Program
1 other identifier
interventional
76
1 country
1
Brief Summary
How can offer support to patients and families through a volunteer caring program based on new technologies? The aim of this study is to implement and evaluate a volunteer training programme in the use of new technologies: ITV-Pal Programme to support patients facing a life-threatening illness and their families. It will created two groups of volunteers, one group will follow the CUDECA standard training program, the other will follow the proposed intervention, ITV-Pal programme. Volunteers will be allocated randomly to each group. Second stage will consist in the implementation of the direct support to patients and families through the volunteers. The expectation is that ITV-Pal volunteers trained will be able to increase general welfare of patients and families they care for. To test it, the quality of life of patients, families and volunteers, the quality of the dying process, and identify how new technology supports volunteer end of life care will be measure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 5, 2021
CompletedFirst Posted
Study publicly available on registry
May 25, 2021
CompletedStudy Start
First participant enrolled
November 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2022
CompletedDecember 10, 2021
November 1, 2021
11 months
April 5, 2021
November 29, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Distress thermometer
Distress is an unpleasant experience of a mental, physical, social, or spiritual nature. It can affect the way you think, feel, or act. Distress may make it harder to cope with having cancer, its symptoms, or its treatment. 0 no distress 10 extreme distress
Through study completion, an average of 3 months
ICECAP-SCM
The ICECAP Supportive Care Measure (ICECAP-SCM) has been developed as a tool for use in economic evaluation conducted in an end of life setting
Through study completion, an average of 15 days
Secondary Outcomes (6)
EuroQoL 5D-5L
Baseline, 15 and 30 days after inclusion.
Satisfaction Volunteer Programme
Through study completion, an average of 12 months
Service Improvement Metrics: fidelity
Through study completion, an average of 12 months
Service Improvement Metrics: dose
Through study completion, an average of 12 months
Service Improvement Metrics: reach
Through study completion, an average of 12 months
- +1 more secondary outcomes
Other Outcomes (5)
PHTech questionnaire
Through study completion, an average of 3 months
Volunteer Motivation (VFI)
Baseline
Age
Baseline
- +2 more other outcomes
Study Arms (2)
Tech-volunteer
EXPERIMENTALA complex intervention with two phases is proposed. * First phase: volunteers new technologies training (tech-volunteering). Volunteers will be trained in the use of NT and their interconnectivity as tools to support their volunteer work. This training will be integrated into the PC volunteer training programme. * Second phase: using the NT with patients and relatives.
Usual volunteer
NO INTERVENTIONthe control group will receive standard volunteer service.
Interventions
Eligibility Criteria
You may qualify if:
- Patients/relatives:
- Over 18 years; PC patients and relatives eligible for volunteer support according to the PC team assessment.
- Acceptance to participate in the study by signing the Informed Consent.
- PC Volunteers:
- \- Acceptance to participate in the study by signing the Informed Consent.
You may not qualify if:
- \- No acceptance to participate in the study by signing the Informed Consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cudeca Hospice Foundationlead
- La Caixa Foundationcollaborator
Study Sites (1)
Fundación CUDECA
Benalmádena, Málaga, 29631, Spain
Related Publications (1)
Barnestein-Fonseca P, Vibora-Martin E, Ruiz-Torreras I, Chapinal-Bascon H, Martin-Rosello ML, Gomez-Garcia R. ITV-Pal programme: protocol of evaluation of the implementation of tech-volunteer programme in palliative care services. BMJ Open. 2023 Aug 24;13(8):e065222. doi: 10.1136/bmjopen-2022-065222.
PMID: 37620277DERIVED
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 5, 2021
First Posted
May 25, 2021
Study Start
November 1, 2021
Primary Completion
September 30, 2022
Study Completion
December 31, 2022
Last Updated
December 10, 2021
Record last verified: 2021-11
Data Sharing
- IPD Sharing
- Will not share